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Abstract
Background: Domestic abuse is a global public health issue. The association between 
the development of central sensitivity syndromes (CSS) and previous exposure to do-
mestic abuse has been poorly understood particularly within European populations.
Methods: A retrospective cohort study using the ‘The Health Improvement Network,’ 
(UK primary care medical records) between 1st January 1995– 31st December 2018. 
22,604 adult women exposed to domestic abuse were age matched to 44,671 unex-
posed women. The average age at cohort entry was 36 years and the median follow-
 up was 2.5 years. The outcomes of interest were the development of a variety of 
syndromes which demonstrate central nervous system sensitization. Fibromyalgia, 
chronic fatigue syndrome and temporomandibular joint disorder outcomes have been 
reported previously. Outcomes were adjusted for the presence of mental ill health.
Results: During the study period, women exposed to domestic abuse experienced an in-
creased risk of developing chronic lower back pain (adjusted incidence rate ratio [aIRR] 
2.28; 95% CI 1.85– 2.80), chronic headaches (aIRR 3.15; 95% CI 1.07– 9.23), irritable 
bowel syndrome (aIRR 1.41; 95% CI 1.25– 1.60) and restless legs syndrome (aIRR 1.89; 
95% CI 1.44– 2.48). However, no positive association was seen with the development 
of interstitial cystitis (aIRR 0.52; 95% CI 0.14– 1.93), vulvodynia (aIRR 0.42; 95% CI 
0.14– 1.25) and myofascial pain syndrome (aIRR 1.01; 95% CI 0.28– 3.61).
Conclusion: This study demonstrates the need to consider a past history of domestic 
abuse in patients presenting with CSS; and also consider preventative approaches in 
mitigating the risk of developing CSS following exposure to domestic abuse.
Significance: Domestic abuse is a global public health issue, with a poorly under-
stood relationship with the development of complex pain syndromes. Using a large 
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
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1 |  INTRODUCTION
Domestic abuse (‘controlling, coercive, threatening behaviour, 
violence or abuse between those >16 who are, or have been, in-
timate partners or family members’) (HM Government, 2016) 
is a global public health problem thought to affect up to one 
in three women (World Health Organization, 2018). Globally, 
6.7 million disability- adjusted life years are thought to be attrib-
utable to intimate partner violence, a form of domestic abuse. 
The burden of morbidity and mortality as a result of associated 
injury, psychological illness or non- communicable disease with 
domestic abuse and traumatic experiences in the household is 
substantial (Bacchus et  al.,  2018; Chandan, Bandyopadhyay 
et al., 2020; Chandan, Keerthy, et al., 2020; Chandan, Okoth, 
et  al.,  2020; Chandan, Thomas, Bradbury- Jones, Taylor, 
et al., 2019; Chandan, Thomas, et al., 2020; Chandan, Thomas, 
Gokhale, et al., 2019).
Exposure to stressful events related to domestic abuse may 
be associated with changes in the hypothalamic- pituitary- 
adrenal (HPA) axis, daily cortisol regulation and ultimately lead 
to altered inflammatory processes (Griffin et al., 2005; Heath 
et al., 2013; Pico- Alfonso et al., 2004). In addition, exposure 
to domestic abuse has been associated with the development 
of poor mental health outcomes and a tendency to adopt harm-
ful lifestyle choices as coping mechanisms (Chandan, Thomas, 
Bradbury- Jones, Russell, et  al.,  2019; Crane et  al.,  2013). A 
cumulation of these bio- psycho- social outcomes of domestic 
abuse have been thought to play a role in the development of 
associated physical and psychological morbidity. Emerging ev-
idence suggests the association between exposure to domestic 
abuse and the development of pain disorders as a result of in-
jury (Petrisor et al., 2013). However, the association of domes-
tic abuse with chronic pain disorders where there is no clear 
injury explaining their cause is not well understood (Chandan, 
Thomas, Bradbury- Jones, Taylor, et al., 2019).
As our understanding of pain has improved, it has been hy-
pothesized that patients experiencing common chronic pain 
disorders may experience sensitization of the central nervous 
system (Nijs et al., 2011, 2019). The accepted umbrella term 
for these conditions is central sensitivity syndromes, and they 
include fibromyalgia; chronic fatigue syndrome; temporo-
mandibular joint disorders; chronic lower back pain; intersti-
tial cystitis; vulvodynia; chronic headaches; myofascial pain 
syndrome; irritable bowel syndrome and restless legs syn-
drome (Moshiree et al., 2006; Nijs et al., 2011). These condi-
tions are characterized by chronic upregulation of peripheral 
nociception which can lead to allodynia and hyperalgesia 
(Latremoliere & Woolf,  2009; Woolf,  2011). The cause of 
central sensitization is not clear, however, it is thought that 
dysregulation of the HPA axis may be an aetiological com-
ponent, and therefore this suggests domestic abuse may play 
a role in the development of CSS (Eller- Smith et al., 2018).
The evidence base associating domestic abuse and CSS 
is scarce, and where present is limited by study design (case- 
control or cross- sectional), low participant numbers or self- 
reported exposure and outcomes (Becker- Dreps et al., 2010; 
Campbell et al., 2002; Perona et al., 2005; Peters et al., 2007; 
Vives- Cases et al., 2011; Wuest et al., 2008). There have yet 
to be any studies exploring an association between domestic 
abuse with the development of chronic headaches, myofas-
cial pain syndrome, vulvodynia or restless legs syndrome. 
Although not specific to domestic abuse, recent studies ex-
amining other traumatic exposures and psycho- social co- 
morbidities with the development of central sensitization 
clearly identifies a plausible relationship which requires more 
investigation due to the largely cross- sectional nature of ex-
isting evidence (McKernan, Johnson, Crofford, et al., 2019; 
McKernan, Johnson, Reynolds, et  al.,  2019; McKernan 
et al., 2018). An approach which overcomes many of the lim-
itations highlighted above, previously adopted by our team, 
was to use a population- based dataset to explore the associ-
ation of domestic abuse with CSS: fibromyalgia, chronic fa-
tigue syndrome and temporomandibular joint disorders using 
an extract of data which ended in 2017 (Chandan, Thomas, 
Bradbury- Jones, Taylor, et  al.,  2019; Chandan, Thomas, 
Raza, et al., 2019).
However, cohort evidence is still needed to explore the 
association with other types of CSS. Therefore, we have con-
ducted the first retrospective cohort study using ‘The Health 
Improvement Network’ (THIN) dataset to explore the asso-
ciation of domestic abuse exposure in women with the sub-
sequent development of chronic lower back pain, interstitial 
cystitis, vulvodynia, chronic headaches, myofascial pain syn-
drome, irritable bowel syndrome and restless legs syndrome.
2 |  METHODS
2.1 | Study design and data source
A population based retrospective open (allowing for patients 
to enter and exit the study at different time points) cohort 
UK primary care database, we were able to conduct the first global cohort study 
to explore this further. We found a strong pain morbidity burden associated with 
domestic abuse, suggesting the need for urgent public health intervention to not only 
prevent domestic abuse but also the associated negative pain consequences.
   | 1285CHANDAN et Al.
study using THIN was conducted. The study period was be-
tween 1st January 1995 and 31st December 2018.
During the study period, the dataset consisted of medical 
records taken from 787 UK general practices and deemed to 
be representative of the UK population (Blak et al., 2011). 
Symptoms, examinations, and diagnoses in THIN are re-
corded using a hierarchical clinical coding system called 
Read codes (Booth,  1994). General practices were eligi-
ble for inclusion 12 months following their installment of 
electronic practice records or from the practice's acceptable 
mortality recording date (Maguire et  al.,  2009). During 
the study period, this left 9,588,734 patients eligible to 
contribute. Data extraction was facilitated using the Data 
Extraction for Epidemiological Research (DExtER) tool 
(Gokhale et al., 2020).
2.2 | Exposure and outcome definition
Each adult (>18 years) woman exposed to domestic abuse 
(the presence of Read code relating to domestic abuse expo-
sure in their medical record) was age matched (± one year) 
with up to two unexposed (no domestic abuse code) women. 
Both the exposed and unexposed group were followed up to 
assess the risk of developing a CSS: chronic lower back pain, 
interstitial cystitis, vulvodynia, chronic headaches, myofas-
cial pain syndrome, irritable bowel syndrome or restless legs 
syndrome.
Exposure code selection relating to domestic abuse has 
been described in our previous work (Chandan, Thomas, 
Bradbury- Jones, Russell, et al., 2019). There are currently no 
validated code lists for CSS outcomes, however, as the mus-
culoskeletal and chronic pain burden of GP consultations is 
extensive (Phillips, 2009). Code lists were created with the 
assistance of co- authors with expertise in primary care and 
Read code selection. To ensure we are including conditions 
relating to CNS sensitization we have not included non- 
specific/acute pain codes (e.g. acute back pain).
Read code lists relating to exposure terms and outcomes 
are provided (Appendix S1).
2.3 | Follow- up period
The index date for those in the exposed group was the date 
of the first Read code relating to domestic abuse exposure 
(incident cases) or when they became eligible to enter the 
study for those with a previous history of exposure (preva-
lent cases). To mitigate immortality time bias (Lévesque 
et  al., 2010), the same index date was assigned to the cor-
responding unexposed patient.
The follow- up period for each patient was from the index 
date until the exit date. Exit date is defined as the earliest of 
the following dates: study end date, last date of data collec-
tion from a given general practice, date patient transferred 
from general practice, date of death or date the outcome of 
interest occurred.
2.4 | Co- variates
Co- variates considered in our modelling were selected due 
to their independent relationship with CSS development: 
age, gender, depression, anxiety, serious mental ill health 
(Chandan, Thomas, Bradbury- Jones, Russell, et al., 2019) and 
Townsend deprivation score (Townsend et al., 1988) which 
were captured at baseline. In addition, data on body mass 
index (BMI), alcohol drinking status and smoking status are 
reported. Psychological covariates (depression, anxiety and 
serious mental illness) were identified following review of 
General practitioner recorded (Read codes) diagnoses of the 
relevant conditions. The code list selection process of these 
covariates has been previously reported (Chandan, Thomas, 
Gokhale, et al., 2019) and notably steps included the reviews 
from general practitioners and a public health clinician with 
a psychiatry background in selection of the final code lists. 
Although there has been no prior published validation of 
these code lists, depression and SMI are thought to be well 
coded as they form part of the Quality Outcomes Framework, 
(NHS Digital, 2019) (performance indicators linked to gen-
eral practice payments in the UK). Additionally, anxiety is 
thought to be well coded as previous studies have demon-
strated a similar prevalence of anxiety measured in THIN da-
tabase compared to pre- existing self- reported national survey 
data (Martin- Merino et al., 2010; Mcmanus et al., 2016).
2.5 | Statistical analysis
Categorical baseline data were described using proportions, 
continuous data were described using means or median with 
standard deviations or inter quartile range. Where there were 
missing data in our covariates, it was treated as a separate 
missing category.
In order to calculate an incidence rate (IR) per 100,000 
person years for each of the outcomes of interest, patients with 
pre- existing illness (defined as a CSS code) were excluded to 
ensure the IR reflected incident outcomes. Poisson regres-
sion offsetting for person years of follow- up was then used 
to calculate an incidence rate ratio (IRR) for each outcome 
of interest during the study period. Following adjustment for 
the co- variates, we calculated and present an adjusted IRR 
(aIRR). IRRs are presented with 95% confidence intervals 
(CI) with statistical significance set at p < .05.
STATA version 15.1 MP/4 software (Statacorp 2017) was 
used to conduct all analyses.
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Despite previously published literature presenting men-
tal illness as potential confounders (Chandan, Thomas, 
Bradbury- Jones, Russell, et  al.,  2019) it is also possible 
they may act as mediators in this relationship. Although 
it was outside of the remit of this study to conduct a me-
diation analysis, a sensitivity analysis was also conducted 
whereby depression, anxiety and serious mental ill health 
were not included in the regression model to give an in-
dication as to the impact of including these covariates as 
control factors.
2.6 | Patient and public involvement
No patients were actively involved in setting the research 
question, outcome measures, study design, results interpreta-
tion of write- up of the results. There are plans for the results 
to be disseminated to the patient community affected by this 
research through domestic abuse charities and social media 
channels.
3 |  RESULTS
3.1 | Baseline characteristics
Of the total eligible patients in the dataset, 22,604 (0.2%) 
adult women were identified as exposed to domestic abuse 
who were matched to 44,671 (0.5%) unexposed women. 
The average age in the cohort was 36 years and follow- up 
was longer in the unexposed group (2.7 years compared to 
2.0 years) due to exposed women transferring practice more 
frequently than the unexposed group. The exposed group had 
a greater prevalence of current smokers and CSS morbidity at 
baseline, in addition to a greater proportion of those in lower 
socioeconomic classes compared to the unexposed group. 
Further details are shown in Table 1 which has been reported 
as per the STROBE guideline without inferential measures 
presented (Vandenbroucke et al., 2007).
3.2 | Cohort findings
During our study period we identified that exposure to 
domestic abuse was associated with the development of 
chronic lower back pain (aIRR 2.28; 95% CI 1.85– 2.80), 
chronic headaches (aIRR 3.15; 95% CI 1.07– 9.23), irrita-
ble bowel syndrome (aIRR 1.41; 95% CI 1.25– 1.60) and 
restless legs syndrome (aIRR 1.89; 95% CI 1.44– 2.48). It 
is important to state that chronic lower back pain (exposed 
IR 307.70; unexposed IR 112.51 per 100,000 py), irritable 
bowel syndrome (exposed IR 750.67; unexposed IR 487.12 
per 100,000 py) and restless legs syndrome (exposed IR 
162.06; unexposed IR 69.59 per 100,000 py) were rela-
tively common occurring outcomes in the dataset, whereas 
there were only nine incident cases of chronic headache in 
the exposed group (IR 12.80 per 100,000 py) and six in the 
unexposed group (3.67 per 100,000 py) during the study 
period.
There was no statistically significant association noted 
with the development of interstitial cystitis (aIRR 0.52; 95% 
CI 0.14– 1.93), vulvodynia (aIRR 0.42; 95% CI 0.14– 1.25) 
and myofascial pain syndrome (aIRR 1.01; 95% CI 0.28– 
3.61). However, the occurrence of these events was also low 
during the study period. Further details are in Table 2 and 
Figure 1.
4 |  DISCUSSION
The key findings from our study demonstrate that exposure 
to domestic abuse in women leads to an increased risk of de-
veloping irritable bowel syndrome, restless legs syndrome, 
chronic headaches and more than a tripling of the risk of de-
veloping chronic lower back pain. Whereas, domestic abuse 
was not clearly associated with the development of inter-
stitial cystitis, vulvodynia and myofascial pain syndrome. 
However, it must be noted that the number of outcomes 
during the study period for non- significant findings and the 
significant finding chronic headaches were low.
F I G U R E  1  The risk of developing 
a central sensitivity syndrome in women 
exposed and unexposed to domestic abuse
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As this was the first study to assess outcomes of CSS 
using UK definitions of domestic abuse, it is not easily pos-
sible to compare our incidence rates with other international 
study findings. Particularly for myofascial pain syndrome, 
chronic headaches, vulvodynia and restless legs syndrome 
these findings are novel. The prevalence of domestic abuse 
exposure has previously been shown to be high in a cohort 
of women who experience irritable bowel syndrome (Perona 
et al., 2005), and our findings are in concurrence with a previ-
ous population- based study including women from Nicaragua 
which showed an increased odds ratio (OR) of having expo-
sure to domestic abuse in women who present with irritable 
bowel syndrome (Becker- Dreps et al., 2010). However, that 
study only included 151 cases of irritable bowel syndrome 
(physical abuse; OR 2.08; 95% CI 1.35– 3.21: sexual abuse: 
OR 2.85; 95% CI 1.45– 5.59) and recall of domestic abuse 
without consideration of temporality. Another cross- sectional 
study in Spain demonstrated an increased odds ratio (OR 
2.34; 95% CI 1.53– 3.57) of having experienced domestic 
abuse in women who present with chronic back pain, but only 
explored the violent form of domestic abuse. The only study 
exploring the relationship between interstitial cystitis and 
domestic abuse identified that within a cohort of 76 women 
with interstitial cystitis, a high proportion (49%) had expe-
rienced domestic abuse, but little further insight was avail-
able in this relationship. Therefore, the findings of our study 
greatly build on previous work in this field.
Our study demonstrates the need to consider a past history 
of domestic abuse in patients presenting with CSS; and also 
consider preventative approaches mitigating the risk of devel-
oping CSS following exposure to domestic abuse.
The use of UK primary care records for epidemiological 
research relies upon the accuracy of documenting by the 
healthcare professionals contributing to the dataset. A lim-
itation of the study is the exposure and outcome Read codes 
have not yet been validated against clinical notes (McBrien 
et  al.,  2018). Previous work conducted using the THIN 
T A B L E  1  Baseline characteristics of women exposed and 
unexposed to domestic abuse






Number of patients 22,604 44,671
Median follow- up 
period (person years)
2.0 (IQR 0.8– 4.2) 2.7 (IQR 
1.2– 5.1)
Age at cohort entry 
(years)
36.1 (SD 12.5) 35.7 (SD 12.3)
Age when abuse 
occurred (years)
33.4 (SD 12.0) - 
Body mass index
<25kg/m2 8,475 (37.5%) 19,352 
(43.3%)
25−30kg/m2 4,054 (17.9%) 9,606 (21.5%)
>30kg/m2 3,451 (15.3%) 8,370 (18.7%)
Not available 6,624 (29.3%) 7,343 (16.4%)
Smoking status
Current smoker 9,039 (40.0%) 9,912 (22.2%)
Non- current smoker 10,534 (46.6%) 33,322 
(74.6%)
Not available 3,031 (13.4%) 1,437 (3.2%)
Drinking status
Non- drinker 5,877 (26.0%) 9,657 (21.6%)
Drinker 10,076 (44.6%) 25,657 
(57.4%)
Not available 6,651 (29.4%) 9,357 (21.0%)
Townsend index
(Least deprived) 1 2008 (8.9%) 7,361 (16.5%)
2 2,469 (10.9%) 7,033 (15.7%)
3 3,758 (16.6%) 8,276 (18.5%)
4 5,032 (22.3%) 8,340 (18.7%)
5 5,049 (22.3%) 6,823 (15.3%)
Not available 4,288 (19.0%) 6,838 (15.3%)
Mental ill health at baseline
Depression 8,679 (38.4%) 7,808 (17.5%)
Anxiety 4,246 (18.8%) 4,388 (9.8%)
Serious mental 
illness
581 (2.6%) 418 (0.9%)
Central sensitivity syndrome at baseline
Chronic lower back 
pain
285 (1.3%) 327 (0.7%)
Interstitial cystitis 20 (0.1%) 23 (0.1%)
Vulvodynia (female) 9 (0.0%) 11 (0.0%)
(Continues)






Chronic headache 9 (0.0%) 16 (0.0%)
Myofascial pain 
syndrome
8 (0.0%) 10 (0.0%)
Irritable bowel 
syndrome
2,184 (9.7%) 3,691 (8.3%)
Restless leg 
syndrome
91 (0.4%) 168 (0.4%)
T A B L E  1  (Continued)
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database exploring the incidence and prevalence of domes-
tic abuse in a primary care cohort suggests that substantial 
under- recording when compared to self- reported national 
survey estimates (Chandan,  2020; Chandan, Gokhale, 
et  al.,  2020; Chandan, Taylor, et  al.,  2020; Jeyaraman & 
Chandan,  2020; Office For National Statistics,  2016). 
Although, it is difficult to assess the representativeness of 
the sample when there is such a level of under- recording, 
when compared to national statistics there are similar pat-
terns in the age and deprivation of domestic abuse survi-
vors (Chandan, Gokhale, et  al.,  2020). Under- recording 
of the exposure is likely to lead to misclassification bias 
where the unexposed group may be incorrectly coded as 
unexposed when they are in fact exposed. Therefore, it is 
possible our findings are an underestimate of the true effect 
size. Alternatively, it is possible that the cases recorded by 
T A B L E  2  The risk of developing a central sensitivity syndrome in women exposed and unexposed to domestic abuse
Chronic headache
Myofascial pain 
syndrome Irritable bowel syndrome Restless leg syndrome
Exposed Unexposed Exposed Exposed Unexposed Unexposed Exposed Unexposed
Number of patients 22,595 44,655 22,596 44,661 20,420 40,980 22,513 44,503
Numbers of 
outcomes
9 6 <5 7 464 719 113 113
Person- years 70,293 163,318 70,321 163,318 61,812 147,603 69,727 162,382
Incidence rate (per 
100,000 person 
years)
12.80 3.67 5.69 4.29 750.67 487.12 162.06 69.59
Incidence rate ratio 
(95% confidence 
intervals)a 
3.49 (1.24– 9.79) 1.33 (0.39– 4.53) 1.54 (1.37– 1.73) 2.33 (1.79– 3.02)
p value 0.018 0.652 <0.001 <0.001
Adjusted incidence 
rate ratio (95% 
confidence 
intervals)b 
3.15 (1.07– 9.23) 1.01 (0.28– 3.61) 1.41 (1.25– 1.60) 1.89 (1.44– 2.48)
p value 0.037 0.990 <0.001 <0.001
Sensitivity analysisc 3.57 (1.26– 10.10) 1.10 (0.32– 3.82) 1.58 (1.41– 1.78) 2.23 (1.72– 2.91)
p value 0.016 0.877 <0.001 <0.001
Chronic lower back pain Interstitial cystitis Vulvodynia
Exposed Unexposed Exposed Unexposed Exposed Unexposed
Number of patients 22,319 44,344 22,584 44,648 22,595 44,660
Numbers of outcomes 212 182 <5 11 <5 21
Person- years 68,898 161,764 70,290 163,250 70,332 163,296
Incidence rate (per 
100,000 person years)
307.70 112.51 4.27 6.74 5.69 12.86
Incidence rate ratio (95% 
confidence intervals)a 
2.73 (2.24– 3.33) 0.63 (0.18– 2.27) 0.44 (0.15– 1.29)
p value <0.001 0.483 0.135
Adjusted incidence rate 
ratio (95% confidence 
intervals)b 
2.28 (1.85– 2.80) 0.52 (0.14– 1.93) 0.42 (0.14– 1.25)
p value <0.001 0.327 0.118
Sensitivity analysisc 2.51 (2.05– 3.07) 0.71 (0.20– 2.60) 0.52 (0.18– 1.54)
p value <0.001 0.610 0.238
aUnadjusted incidence rate ratio. 
bAdjusted Incidence rate ratio: adjusted for age, gender, depression, anxiety, serious mental ill health and Townsend deprivation score at baseline. 
cSensitivity analysis: adjusted for age, gender and Townsend deprivation score at baseline. 
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healthcare practitioners are the most severe which we are 
unable to discern in this study. Equally, it is clear that our 
results show a likely under- recording of CSS in the pri-
mary care population. In total across the study period 8,334 
women (12.4%) had a recorded CSS of any type, which 
when compared to nationally accepted prevalence statis-
tics of sub- types of CSS such as IBS (National Institute of 
Health & Care Excellence, 2015) indicates under- recording 
in this dataset. Although there is no published literature 
suggesting a surveillance bias in those exposed to domestic 
abuse, this may still be possible and in fact could lead to 
more women being identified to having a diagnosis of CSS, 
suggesting our effect sizes may in fact be an over- estimate. 
Additionally, although it is anticipated that recording of 
mental health conditions is expected to be relatively repre-
sentative of the burden of disease in the general population, 
there is also a possibility of under- recording as there is still 
no formal validation of these clinical code lists.
Lastly, although in the main analysis we have accounted 
for mental illness and other important confounders as po-
tential confounders, in this study we have been unable to 
explore the causal pathway for this relationship. This may 
mean that there is a possibility that some of the covariates 
selected such as mental illness may in fact be mediators in 
the relationship pathway rather than moderators. Although, 
we were unable to conduct a mediation analysis in this study, 
we have presented a sensitivity analysis (seen in Table  2) 
which demonstrated that when removing mental illness from 
the adjustment covariates there was no substantial change or 
variation in the nature of the effect size when examining the 
outcomes. Future research should be directed to establish the 
nature of the pathway between domestic abuse and CSS, as 
an increased understanding of the role of differing mediators 
and moderators may provide insight in the development and 
delivery of interventions aiming to prevent morbidity subse-
quent to domestic abuse exposure.
In conclusion, our study showed an increased risk of many 
types of CSS following exposure to domestic abuse. Primary 
prevention approaches targeting domestic abuse as well as 
secondary preventative approaches should be developed (or 
continued where provision exists) to minimize the associated 
burden of CSS.
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